Sherman G. Souther
@Vr Adviser, Llc
Latest period2024 - Q3ReportedManaged Assets$1.909BTotal holdings38
Assets growth rate21.59%Assets growth rate (2-Q avg)-1.85%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Vr Adviser, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 38 positions.
Assets under management
The assets under management (AUM) of Vr Adviser, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.909B in assets, with a quarterly growth rate of 21.59% and a 2-quarter average growth rate of -1.85%. The portfolio is managed by Sherman G. Souther, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
EWTXEdgewise Therapeutics Inc
| 1.4% | $26.69M 1M shares@ $26.69 avg price | Decreased -45% |
ARTVArtiva Biotherapeutics Inc
| 1.31% | $24.868M 1.61M shares@ $15.45 avg price | New Position |
ENGNEngene Holdings Inc
| 1.24% | $23.535M 3.566M shares@ $6.61 avg price | Increased 26.19% |
CGEMCullinan Therapeutics Inc
| 1.21% | $23.101M 1.38M shares@ $16.74 avg price | |
MRSNMersana Therapeutics Inc
| 1.13% | $21.41M 11.328M shares@ $1.89 avg price | |
TSHATaysha Gene Therapies Inc
| 0.95% | $18.09M 9M shares@ $2.01 avg price | |
ABVXAbivax Sa
| 0.82% | $15.503M 1.346M shares@ $11.53 avg price | |
TRVITrevi Therapeutics Inc
| 0.6% | $11.432M 3.423M shares@ $3.34 avg price | Increased 0.01% |
ARVNArvinas Inc
| 0.59% | $11.193M 454,450 shares@ $24.64 avg price | Decreased -27.61% |
ADVMAdverum Biotechnologies Inc
| 0.54% | $10.299M 1.467M shares@ $7.03 avg price |